The Pellino family: IRAK E3 ligases with emerging roles in innate immune signalling

Trends in Immunology

Volumn 30, Issue 1, 2009, Pages 33-42

  Moynagh, Paul N ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE; PELLINO 1 PROTEIN; PELLINO 2 PROTEIN; PELLINO 3 PROTEIN; PROTEIN DERIVATIVE; TOLL LIKE RECEPTOR; TRANSCRIPTION FACTOR; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG;

CATALYSIS; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HUMAN; INNATE IMMUNITY; NONHUMAN; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN TARGETING; REVIEW; SIGNAL TRANSDUCTION; UBIQUITINATION;

ANIMALS; HUMANS; IMMUNITY, INNATE; INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES; NUCLEAR PROTEINS; PROTEIN BINDING; SIGNAL TRANSDUCTION; UBIQUITIN-PROTEIN LIGASES;

EID: 58149240784     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.it.2008.10.001     Document Type: Review

References (64)

1. Janeway Jr. C.A., and Medzhitov R. Innate immune recognition. Annu. Rev. Immunol. 20 (2002) 197-216
2. Martin M.U., and Wesche H. Summary and comparison of the signaling mechanisms of the Toll/interleukin-1 receptor family. Biochim. Biophys. Acta 1592 (2002) 265-280
3. Medzhitov R., et al. MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways. Mol. Cell 2 (1998) 253-258
4. O'Neill L.A., and Bowie A.G. The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nat. Rev. Immunol. 7 (2007) 353-364
5. Li S., et al. IRAK-4: a novel member of the IRAK family with the properties of an IRAK-kinase. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 5567-5572
6. Cao Z., et al. IRAK: a kinase associated with the interleukin-1 receptor. Science 271 (1996) 1128-1131
7. Lye E., et al. The role of interleukin 1 receptor-associated kinase-4 (IRAK-4) kinase activity in IRAK-4-mediated signaling. J. Biol. Chem. 279 (2004) 40653-40658
8. Kollewe C., et al. Sequential autophosphorylation steps in the interleukin-1 receptor-associated kinase-1 regulate its availability as an adapter in interleukin-1 signaling. J. Biol. Chem. 279 (2004) 5227-5236
9. Burns K., et al. Tollip, a new component of the IL-1RI pathway, links IRAK to the IL-1 receptor. Nat. Cell Biol. 2 (2000) 346-351
10. Jiang Z., et al. Interleukin-1 (IL-1) receptor-associated kinase-dependent IL-1-induced signaling complexes phosphorylate TAK1 and TAB2 at the plasma membrane and activate TAK1 in the cytosol. Mol. Cell. Biol. 22 (2002) 7158-7167
11. Takatsuna H., et al. Identification of TIFA as an adapter protein that links tumor necrosis factor receptor-associated factor 6 (TRAF6) to interleukin-1 (IL-1) receptor-associated kinase-1 (IRAK-1) in IL-1 receptor signaling. J. Biol. Chem. 278 (2003) 12144-12150
12. Deng L., et al. Activation of the IκB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell 103 (2000) 351-361
13. Wang C., et al. TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature 412 (2001) 346-351
14. Cheung P.C., et al. TAB3, a new binding partner of the protein kinase TAK1. Biochem. J. 378 (2004) 27-34
15. Kanayama A., et al. TAB2 and TAB3 activate the NF-κB pathway through binding to polyubiquitin chains. Mol. Cell 15 (2004) 535-548
16. Windheim M., et al. Interleukin-1 (IL-1) induces the Lys63-linked polyubiquitination of IL-1 receptor-associated kinase 1 to facilitate NEMO binding and the activation of IκBα kinase. Mol. Cell. Biol. 28 (2008) 1783-1791
17. Kishida S., et al. TAK1-binding protein 2 facilitates ubiquitination of TRAF6 and assembly of TRAF6 with IKK in the IL-1 signaling pathway. Genes Cells 10 (2005) 447-454
18. Jacinto R., et al. Lipopolysaccharide- and lipoteichoic acid-induced tolerance and cross-tolerance: distinct alterations in IL-1 receptor-associated kinase. J. Immunol. 168 (2002) 6136-6141
19. Yamin T.T., and Miller D.K. The interleukin-1 receptor-associated kinase is degraded by proteasomes following its phosphorylation. J. Biol. Chem. 272 (1997) 21540-21547
20. Ninomiya-Tsuji J., et al. The kinase TAK1 can activate the NIK-I κB as well as the MAP kinase cascade in the IL-1 signalling pathway. Nature 398 (1999) 252-256
21. Yi A.K., and Krieg A.M. CpG DNA rescue from anti-IgM-induced WEHI-231 B lymphoma apoptosis via modulation of IκB αand IκB β and sustained activation of nuclear factor-κB/c-Rel. J. Immunol. 160 (1998) 1240-1245
22. Medzhitov R., et al. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388 (1997) 394-397
23. O'Neill L.A. Signal transduction pathways activated by the IL-1 receptor/toll-like receptor superfamily. Curr. Top. Microbiol. Immunol. 270 (2002) 47-61
24. Beinke S., et al. Lipopolysaccharide activation of the TPL-2/MEK/extracellular signal-regulated kinase mitogen-activated protein kinase cascade is regulated by IκB kinase-induced proteolysis of NF-κB1 p105. Mol. Cell. Biol. 24 (2004) 9658-9667
25. Mendoza H., et al. Roles for TAB1 in regulating the IL-1-dependent phosphorylation of the TAB3 regulatory subunit and activity of the TAK1 complex. Biochem. J. 409 (2008) 711-722
26. Zhong J., and Kyriakis J.M. Dissection of a signaling pathway by which pathogen-associated molecular patterns recruit the JNK and p38 MAPKs and trigger cytokine release. J. Biol. Chem. 282 (2007) 24246-24254
27. Zhong J., and Kyriakis J.M. Germinal center kinase is required for optimal Jun N-terminal kinase activation by Toll-like receptor agonists and is regulated by the ubiquitin proteasome system and agonist-induced, TRAF6-dependent stabilization. Mol. Cell. Biol. 24 (2004) 9165-9175
28. Dong C., et al. MAP kinases in the immune response. Annu. Rev. Immunol. 20 (2002) 55-72
29. Conze D.B., et al. Lys63-linked polyubiquitination of IRAK-1 is required for interleukin-1 receptor- and toll-like receptor-mediated NF-κB activation. Mol. Cell. Biol. 28 (2008) 3538-3547
30. Rothwarf D.M., et al. IKK-γ is an essential regulatory subunit of the IκB kinase complex. Nature 395 (1998) 297-300
31. Ea C.K., et al. Activation of IKK by TNFα requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO. Mol. Cell 22 (2006) 245-257
32. Wu C.J., et al. Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-κB activation. Nat. Cell Biol. 8 (2006) 398-406
33. Xiao H., et al. Pellino 3b negatively regulates interleukin-1-induced TAK1-dependent NF κB activation. J. Biol. Chem. 283 (2008) 14654-14664
34. Grosshans J., et al. Oligomerisation of Tube and Pelle leads to nuclear localisation of dorsal. Mech. Dev. 81 (1999) 127-138
35. Yu K.Y., et al. Cutting edge: mouse pellino-2 modulates IL-1 and lipopolysaccharide signaling. J. Immunol. 169 (2002) 4075-4078
36. Jiang Z., et al. Pellino 1 is required for interleukin-1 (IL-1)-mediated signaling through its interaction with the IL-1 receptor-associated kinase 4 (IRAK4)-IRAK-tumor necrosis factor receptor-associated factor 6 (TRAF6) complex. J. Biol. Chem. 278 (2003) 10952-10956
37. Jensen L.E., and Whitehead A.S. Pellino3, a novel member of the Pellino protein family, promotes activation of c-Jun and Elk-1 and may act as a scaffolding protein. J. Immunol. 171 (2003) 1500-1506
38. Rich T., et al. Pellino-related sequences from Caenorhabditis elegans and Homo sapiens. Immunogenetics 52 (2000) 145-149
39. Resch K., et al. Assignment of homologous genes, Peli1/PELI1 and Peli2/PELI2, for the Pelle adaptor protein Pellino to mouse chromosomes 11 and 14 and human chromosomes 2p13.3 and 14q21, respectively, by physical and radiation hybrid mapping. Cytogenet. Cell Genet. 92 (2001) 172-174
40. Strelow A., et al. Characterization of Pellino2, a substrate of IRAK1 and IRAK4. FEBS Lett. 547 (2003) 157-161
41. Butler M.P., et al. Pellino3 is a novel upstream regulator of p38 MAPK and activates CREB in a p38-dependent manner. J. Biol. Chem. 280 (2005) 27759-27768
42. Butler M.P., et al. Kinase-active interleukin-1 receptor-associated kinases promote polyubiquitination and degradation of the Pellino family: direct evidence for PELLINO proteins being ubiquitin-protein isopeptide ligases. J. Biol. Chem. 282 (2007) 29729-29737
43. Schauvliege R., et al. Pellino proteins are more than scaffold proteins in TLR/IL-1R signalling: a role as novel RING E3-ubiquitin-ligases. FEBS Lett. 580 (2006) 4697-4702
44. Choi K.C., et al. Smad6 negatively regulates interleukin 1-receptor-Toll-like receptor signaling through direct interaction with the adaptor Pellino-1. Nat. Immunol. 7 (2006) 1057-1065
45. Ordureau A., et al. The IRAK-catalysed activation of the E3 ligase function of Pellino isoforms induces the Lys63-linked polyubiquitination of IRAK1. Biochem. J. 409 (2008) 43-52
46. Schauvliege R., et al. Pellino proteins: novel players in TLR and IL-1R signalling. J. Cell. Mol. Med. 11 (2007) 453-461
47. Jensen L.E., and Whitehead A.S. Pellino2 activates the mitogen activated protein kinase pathway. FEBS Lett. 545 (2003) 199-202
48. Dejardin E., et al. The lymphotoxin-β receptor induces different patterns of gene expression via two NF-κB pathways. Immunity 17 (2002) 525-535
49. Liu Y., et al. BCL10 mediates lipopolysaccharide/toll-like receptor-4 signaling through interaction with Pellino2. J. Biol. Chem. 279 (2004) 37436-37444
50. Newton K., et al. Ubiquitin chain editing revealed by polyubiquitin linkage-specific antibodies. Cell 134 (2008) 668-678
51. Kulkarni A.B., et al. Transforming growth factor β 1 null mutation in mice causes excessive inflammatory response and early death. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 770-774
52. McCartney-Francis N., et al. Aberrant Toll receptor expression and endotoxin hypersensitivity in mice lacking a functional TGF-β 1 signaling pathway. J. Immunol. 172 (2004) 3814-3821
53. Berlato C., et al. Involvement of suppressor of cytokine signaling-3 as a mediator of the inhibitory effects of IL-10 on lipopolysaccharide-induced macrophage activation. J. Immunol. 168 (2002) 6404-6411
54. Stoiber D., et al. Lipopolysaccharide induces in macrophages the synthesis of the suppressor of cytokine signaling 3 and suppresses signal transduction in response to the activating factor IFN-γ. J. Immunol. 163 (1999) 2640-2647
55. Weighardt H., et al. Identification of a TLR4- and TRIF-dependent activation program of dendritic cells. Eur. J. Immunol. 34 (2004) 558-564
56. Sun Y., et al. Toll-like receptor 4 signaling plays a role in triggering periodontal infection. FEMS Immunol. Med. Microbiol. 52 (2008) 362-369
57. Moynagh P.N. TLR signalling and activation of IRFs: revisiting old friends from the NF-κB pathway. Trends Immunol. 26 (2005) 469-476
58. Hotta K., et al. Brachyury-downstream notochord genes and convergent extension in Ciona intestinalis embryos. Dev. Growth Differ. 49 (2007) 373-382
59. Hotta K., et al. Characterization of Brachyury-downstream notochord genes in the Ciona intestinalis embryo. Dev. Biol. 224 (2000) 69-80
60. Hershko A., and Ciechanover A. The ubiquitin system. Annu. Rev. Biochem. 67 (1998) 425-479
61. Liu Y.C., et al. Immunity by ubiquitylation: a reversible process of modification. Nat. Rev. Immunol. 5 (2005) 941-952
62. Chen Z.J. Ubiquitin signalling in the NF-κB pathway. Nat. Cell Biol. 7 (2005) 758-765
63. Freemont P.S. RING for destruction?. Curr. Biol. 10 (2000) R84-R87
64. Joazeiro C.A., and Weissman A.M. RING finger proteins: mediators of ubiquitin ligase activity. Cell 102 (2000) 549-552